SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of MacroGenics, Inc. (NASDAQ: MGNX), Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), Teradata Corporation (NYSE: TDC), and Maplebear Inc. (NYSE: CART).
MacroGenics, Inc. (NASDAQ: MGNX)
Johnson Fistel, LLP is investigating potential claims on behalf of MacroGenics, Inc. against certain of its officers and directors.
If you are a current, long-term shareholder of MacroGenics, you can click or copy and paste the link below in a browser to join this action:
Recently a class action lawsuit was filed against the company. According to the lawsuit, throughout the Class Period, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts related to early interim safety data results from the TAMARACK Phase 2 study. The claims arise on May 9, 2024, when MacroGenics presented interim updated safety and efficacy data for its cancer treatment study TAMARACK.
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)
Johnson Fistel LLP is investigating potential claims on behalf of Apellis Pharmaceuticals against certain of its officers and directors.
If you have continuously owned Apellis Pharmaceuticals shares since before January 28, 2021, submit your information below:
Recently a class action lawsuit was filed against the company. According to the complaint, during the class period, defendants represented SYFOVRE “demonstrated a favorable safety profile” with minimal adverse effects and “no events of retinal vasculitis or retinal vein occlusion” observed. Notwithstanding defendants’ claims regarding the safety of SYFOVRE, on July 15, 2023, the American Society of Retina Specialists (“ASRS”) published a letter highlighting concerns with SYFOVRE. Specifically, the ASRS indicated that physicians have reported cases of eye inflammation in patients treated with SYFOVRE, including six instances of occlusive retinal vasculitis, a type of inflammation that blocks blood flow through the vessels that feed the retina and potentially results in blindness. On this news, the price of Apellis common stock declined $32.04 per share, or nearly 38%, to close at $52.46 per share on July 17, 2023.
Teradata Corporation (NYSE: TDC)
Johnson Fistel, LLP is investigating potential claims on behalf of Teradata Corporation against certain of its officers and directors.
If you are a current, long-term shareholder holding shares before February 13, 2023, you can click or copy and paste the link below in a browser to join this action:
Recently a class action lawsuit was filed against the company. The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements about the company’s business, operations, and compliance policies. They failed to disclose that: (i) under Teradata’s expanded business model, transactions with customers took longer to finalize; (ii) Teradata overstated its ability to close these transactions within the expected timeframes; (iii) it failed to timely close several transactions included in its 2023 ARR growth forecast; (iv) consequently, it was unlikely to meet its 2023 Total and Public Cloud ARR expectations; and (v) the company’s public statements were materially false and misleading.
Maplebear Inc. (NYSE: CART)
Johnson Fistel, LLP is investigating potential claims on behalf of Maplebear Inc. against certain of its officers and directors.
If you are a current, long-term shareholder of Maplebear Inc. holding shares before December 23, 2023, you can click or copy and paste the link below in a browser to join this action:
Recently a class action lawsuit was filed against the company. According to the Complaint, Instacart provides online grocery shopping services to households in North America. The Company sells and delivers a range of products in the food, alcohol, consumer health, pet care, and ready-made meals categories, in addition to others. The Company offers its services through a mobile application and website, while also providing software-as-a-service solutions to retailers.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact:
Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com
